Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
GL Stock Forecast 2026-2027
$157.13
Current Price
$12.20B
Market Cap
Buy 8
Hold 3
Sell 0
Wall St Analyst Ratings
Distance to GL Price Targets
+32.4%
To High Target of $208.00
+14.6%
To Median Target of $180.00
-6.4%
To Low Target of $147.00
GL Price Momentum
+4.0%
1 Week Change
+4.0%
1 Month Change
+30.2%
1 Year Change
+12.3%
Year-to-Date Change
-1.4%
From 52W High of $159.36
+34.6%
From 52W Low of $116.73
📊 TOP ANALYST CALLS
Did GL Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Globe Life is one of their latest high-conviction picks.
Latest GL Stock Price Targets & Analyst Predictions
Based on our analysis of 4 Wall Street analysts, GL has a bullish consensus with a median price target of $180.00 (ranging from $147.00 to $208.00). The overall analyst rating is Strong Buy (8.2/10). Currently trading at $157.13, the median forecast implies a 14.6% upside. This outlook is supported by 8 Buy, 3 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
GL Analyst Ratings
8
Buy
3
Hold
0
Sell
GL Price Target Range
Low
$147.00
Average
$180.00
High
$208.00
Current: $157.13
Latest GL Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for GL.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| May 26, 2026 | Piper Sandler | John Barnidge | Overweight | Maintains | $175.00 |
| May 21, 2026 | Morgan Stanley | Bob Huang | Overweight | Maintains | $181.00 |
| Apr 24, 2026 | Truist Securities | Buy | Maintains | $N/A | |
| Apr 10, 2026 | Wells Fargo | Overweight | Maintains | $N/A | |
| Mar 26, 2026 | Keefe, Bruyette & Woods | Ryan Krueger | Outperform | Reinstates | $168.00 |
| Feb 25, 2026 | Wells Fargo | Overweight | Maintains | $N/A | |
| Feb 18, 2026 | Evercore ISI Group | In-Line | Maintains | $N/A | |
| Feb 6, 2026 | Truist Securities | Buy | Maintains | $N/A | |
| Feb 5, 2026 | JP Morgan | Overweight | Maintains | $N/A | |
| Dec 11, 2025 | TD Cowen | Buy | Maintains | $N/A | |
| Nov 17, 2025 | Morgan Stanley | Overweight | Maintains | $N/A | |
| Oct 28, 2025 | Keefe, Bruyette & Woods | Outperform | Maintains | $N/A | |
| Oct 24, 2025 | Truist Securities | Buy | Maintains | $N/A | |
| Oct 24, 2025 | Wells Fargo | Overweight | Maintains | $N/A | |
| Oct 8, 2025 | Wells Fargo | Overweight | Maintains | $N/A | |
| Aug 18, 2025 | Morgan Stanley | Overweight | Maintains | $N/A | |
| Aug 5, 2025 | Morgan Stanley | Overweight | Upgrade | $N/A | |
| Jul 30, 2025 | BMO Capital | Market Perform | Maintains | $N/A | |
| Jul 29, 2025 | Keefe, Bruyette & Woods | Outperform | Maintains | $N/A | |
| Jul 28, 2025 | Keefe, Bruyette & Woods | Outperform | Maintains | $N/A |
Globe Life Inc. (GL) Competitors
The following stocks are similar to Globe Life based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Globe Life Inc. (GL) Financial Data
Globe Life Inc. has a market capitalization of $12.20B with a P/E ratio of 11.0x. The company generates $6.07B in trailing twelve-month revenue with a 19.4% profit margin.
Revenue growth is +5.4% quarter-over-quarter, while maintaining an operating margin of +23.7% and return on equity of +20.5%.
Valuation Metrics
Market Cap
$12.20B
Enterprise Value
$15.18B
P/E Ratio
11.0x
PEG Ratio
0.8x
Price/Sales
2.0x
Growth & Margins
Revenue Growth (YoY)
+5.4%
Gross Margin
N/A
Operating Margin
+23.7%
Net Margin
+19.4%
EPS Growth
+6.3%
Financial Health
Cash/Price Ratio
+3.6%
Current Ratio
0.7x
Debt/Equity
53.6x
ROE
+20.5%
ROA
+3.3%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Globe Life Inc. (GL) Business Model
About Globe Life Inc.
What They Do
Provides life and supplemental health insurance services.
Business Model
The company operates through subsidiaries that sell individual life insurance, supplemental health insurance, and annuities, targeting lower to middle-income customers. It generates revenue by issuing insurance policies and collecting premiums, while also investing in fixed maturities to support its insurance obligations.
Additional Information
Founded in 1979 and headquartered in McKinney, Texas, Globe Life Inc. has a strong presence in the U.S. insurance market, utilizing exclusive agency forces and direct-to-consumer channels for its sales.
Company Information
Sector
Financial Services
Industry
Insurance - Life
Employees
3,732
CEO
Mr. Frank Martin Svoboda
Country
United States
IPO Year
1979
Website
www.home.globelifeinsurance.comGlobe Life Inc. (GL) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Buy 5 Stocks With High ROE as Markets Swing on War Skirmishes
ROST joins TEL, CVE, GL and SCHW high-ROE cash cows screened for $1B+ cash flow as markets whip on Iran-U.S. skirmishes.
Jun 05, 2026
By Supriyo Bose
Analyst Blog
Latest News
Quick Summary
Shareholders can discuss their rights and options with the firm at no cost. Legal services are offered on a contingency fee basis, with no upfront payment required.
Why It Matters
Indications of shareholder engagement may signal potential legal issues or corporate governance concerns, impacting stock performance and investor sentiment.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
ROST, along with TEL, CVE, GL, and SCHW, is identified as a high-ROE cash cow with over $1B in cash flow amid market volatility due to Iran-U.S. tensions.
Why It Matters
ROST's inclusion in high-ROE cash cows indicates strong financial health and cash flow potential, signaling stability amid market volatility, which can attract investor interest.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Globe Life (GL) recently reported earnings. Investors should monitor upcoming developments and analyst insights for future stock performance.
Why It Matters
Globe Life's recent earnings report may influence stock performance, impacting investor sentiment and potential price movements based on financial health and future guidance.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Morgan Stanley stock is currently in a buy zone. A biometric identity company has reached a new high after rebounding from a previous sell signal.
Why It Matters
Morgan Stanley's favorable position suggests potential for growth, while the biometric identity stock's rebound indicates investor confidence, signaling opportunities in these sectors.
Source: Investors Business Daily
Market Sentiment:
Positive
Quick Summary
Accident and Health Insurance stocks (AFL, UNM, GL, TRUP, EIG) may benefit from increased underwriting and digitalization, though face pricing pressure from rising medical costs and inflation.
Why It Matters
Rising underwriting exposure and digitalization could boost Accident and Health Insurance stocks, but pricing pressure from medical costs and inflation poses risks to profitability.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Zacks Style Scores can assist investors in selecting strong, market-beating stocks for their portfolios.
Why It Matters
Zacks Style Scores can guide investors in selecting stocks with strong potential, enhancing portfolio performance and potentially leading to higher returns.
Source: Zacks Investment Research
Market Sentiment:
Positive
Frequently Asked Questions About GL Stock
What is Globe Life Inc.'s (GL) stock forecast for 2026?
Based on our analysis of 4 Wall Street analysts, Globe Life Inc. (GL) has a median price target of $180.00. The highest price target is $208.00 and the lowest is $147.00.
Is GL stock a good investment in 2026?
According to current analyst ratings, GL has 8 Buy ratings, 3 Hold ratings, and 0 Sell ratings. The stock is currently trading at $157.13. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for GL stock?
Wall Street analysts predict GL stock could reach $180.00 in the next 12 months. This represents a 14.6% increase from the current price of $157.13. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Globe Life Inc.'s business model?
The company operates through subsidiaries that sell individual life insurance, supplemental health insurance, and annuities, targeting lower to middle-income customers. It generates revenue by issuing insurance policies and collecting premiums, while also investing in fixed maturities to support its insurance obligations.
What is the highest forecasted price for GL Globe Life Inc.?
The highest price target for GL is $208.00 from at , which represents a 32.4% increase from the current price of $157.13.
What is the lowest forecasted price for GL Globe Life Inc.?
The lowest price target for GL is $147.00 from at , which represents a -6.4% decrease from the current price of $157.13.
What is the overall GL consensus from analysts for Globe Life Inc.?
The overall analyst consensus for GL is bullish. Out of 4 Wall Street analysts, 8 rate it as Buy, 3 as Hold, and 0 as Sell, with a median price target of $180.00.
How accurate are GL stock price projections?
Stock price projections, including those for Globe Life Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 9, 2026 2:50 AM UTC